DUBLIN, Feb. 11, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/b9xkxb/triptans) has announced the addition of the "Concise Analysis of the International Triptans Products, Pipelines, Players, Patents and Prospects" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Triptans consist of a class of drugs called selective 5-hydroxytryptamine subtype 1 (5-HT1) receptor agonists. Migraine headaches are an established and growing market for patient-friendly drug delivery. Triptans constrict blood vessels in the brain and relieve swelling, a mechanism that is thought to provide palliative relief to migraine patients, but also have other properties that may help treat migraine symptoms.

Worldwide, the highest prevalence of migraine occurs in North America. It is approximately 25 percent less frequent in Europe and Central and South America and approximately 67 percent less frequent in Asia and Africa. Most patients with migraine begin having the headaches in childhood, adolescence or early adulthood.

The market and growth prospects for migraine therapeutics are substantial and have attracted an expanding list of players.

Highlights

• Analyzes and evaluates triptan drug classes and products and development-stage candidates and assesses risks and market potential
• Provides assessments of indications and markets for triptans and examines key market and commercialization factors
• Evaluates the impact of economic, technology, and regulatory factors on triptan drug commercialization
• Provides market data and forecasts to 2018
• Profiles market sector participants, their product development activities and business strategies

Key Topics Covered:

Executive Summary

The Market Opportunity

Market Dynamics
Indications and Prescribing
Demand Drivers
Competitive Landscape
Risks and Opportunities

Triptan Drug Classes

Almotriptans
Eletriptans
Frovatriptans
Naratriptans
Rizatriptans
Sumatriptans
Zolitriptans

Triptan Drug Products - Analysis, Market Data and Forecasts

Almotriptans
Branded Drugs
Patents & Exclusivity
Generics Outlook
Eletriptans
Branded Drugs
Patents & Exclusivity
Generics Outlook
Frovatriptans
Branded Drugs
Patents & Exclusivity
Generics Outlook
Naratriptans
Branded Drugs
Patents & Exclusivity
Generics Outlook
Rizatriptans
Branded Drugs
Patents & Exclusivity
Generics Outlook
Sumatriptans
Branded Drugs
Patents & Exclusivity
Generics Outlook
Zopitriptans
Branded Drugs
Patents & Exclusivity
Generics Outlook

Market Factors

Regulatory Issues
Patient Compliance and Ease of Use
Healthcare Economics

Company Profiles

For more information visit http://www.researchandmarkets.com/research/b9xkxb/triptans

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets